News

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...
A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized ...
We look at the continued turmoil within the FDA, including the forced dismissal of top gene therapy regulator Nicole Verdun, ...
In a study of human immune cells infected with HIV, the virus that causes AIDS, scientists at Johns Hopkins Medicine say a ...
Gene therapy has proved to be a safe long-term treatment for haemophilia B. The benefits of a single dose persist for at ...
Isaralgagene civaparvovec is a “potential best-in-class gene therapy for Fabry disease,” according to analysts at H.C.
A pivotal medical milestone has been reached. For the first time ever, researchers have used a personalized CRISPR-based gene therapy to treat an infant’s rare and life-threatening illness.
The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.
PHILADELPHIA, PA — Passage Bio, Inc. (NASDAQ: PASG) has announced encouraging updates from the ongoing Phase 1/2 upliFT-D ...
News broke yesterday that researchers in Philadelphia appear to have successfully treated a 6-month-old baby boy, called KJ, with a personalized CRISPR gene-editing therapy.The treatment corrects ...
New gene therapy improves the life of 18-year-old with Sickle Cell Disease which affects 5,000 New Jersey residents living with the condition. Skip to Article. Set weather.
K.J. Muldoon, an infant in Philadelphia, has been treated with a personalized Crispr gene-editing therapy for a rare and deadly disease. Photo: Muldoon family.